HopeStage
Back to all studies
WithdrawnNCT05357040

Antidepressant Effects of Nitrous Oxide

Medication studyAges 18+United States + AustraliaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Chicago and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 30, 2021
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of Chicago
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Australia
Age range
Over 18 Years
Official registry ID
NCT05357040
Official title
Show the full official title

Evaluation of the Antidepressant Effects of Nitrous Oxide in People With Major Depressive Disorder

Recruitment & locations

Withdrawn

Chicago, United States · Melbourne, Australia

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Chicago, a university.

Does this study involve medication?

Yes. The study involves medication, including Nitrous oxide gas for inhalation and Placebo.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies